Prelude Therapeutics
PRLD
PRLD
61 hedge funds and large institutions have $1.12B invested in Prelude Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+4
Holders Change %
+7.02%
% of All Funds
1.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
25
Reduced
13
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$23.7M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$220M |
| 3 |
3
Norges Bank
Oslo,
Norway
|
$6.95M |
| 4 |
4
UBS AM
Chicago,
Illinois
|
$46.4M |
| 5 |
5
Massachusetts Financial Services
Boston,
Massachusetts
|
$14.8M |
